"For the first time, US researchers have used a combination of genome editing and antiretroviral therapy (ART) to eliminate the human immunodeficiency virus (HIV) from mice.
The study combines CRISPR/Cas9 technology which was used to remove viral DNA from the infected mice with a therapy that reduces the overall presence of HIV in the animal tissues, resulting in one-third of mice to be completely virus-free upon treatment."